-Reuters
A Look Into Kirby’s Debt
Over the past three months, shares of Kirby (NYSE:KEX) decreased by 2.56%. Before having a look at the importance of debt, let us look at how much debt Kirby has.
Related Posts
aTyr Pharma Shares Ascend As FDA Grants Fast Track Status To Lung Disease Candidate
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod (ATYR1923), for the treatment of pulmonary sarcoidosis, a major form of interstitial lung disease.
EXCLUSIVE: Trulieve CEO On Harvest Deal, Shifting Cannabis Industry Focus, Social Equity
Trulieve Cannabis Corporation (OTCQX: TCNNF) CEO Kim Rivers opened day two of the Benzinga Cannabis Capital Conference Friday with Cheddar Reporter Chloe Aiello.
Morgan Stanley Maintains Overweight on Stevanato Group, Raises Price Target to $27
Morgan Stanley analyst Drew Ranieri maintains Stevanato Group (NYSE:STVN) with a Overweight and raises the price target from $22 to $27.